Bob D. Brown

Suggest Changes
Learn More
BACKGROUND Oblimersen, an ODN targeting BCL-2 RNA, has been shown to be effective in reducing BCL-2 expression in vitro and in in vivo models engineered to overexpress BCL-2. The present study(More)